Ophthalmology

Top Story

Reading speed suitable outcome measure for lampalizumab trials

Reading speed suitable outcome measure for lampalizumab trials
February 11, 2016

MIAMI — Results of the MAHALO study support the use of reading speed as a secondary outcome measure in clinical trials for lampalizumab, a speaker told colleagues here.

Lampalizumab (Roche) is a monoclonal antibody fragment that targets factor D and inhibits the progression of geographic atrophy.

Breaking NewsFrom OSN Europe

Ophthalmic community grieves Cesare Forlini, brilliant and tireless innovator of ocular surgery

February 11, 2016
Cesare Forlini, MD, an internationally acclaimed vitreoretinal surgeon, passed away Feb. 9, ending what he himself defined as “a fierce fight in the mouth of the…

Publication Exclusive: Micropulse transscleral diode laser cyclophotocoagulation an option for refractory glaucoma

February 11, 2016
Glaucoma can be a difficult management problem in a subset of patients, even for the most experienced glaucoma specialists. The treatment spectrum includes drugs…
Breaking News

AKB-9778 improves underlying diabetic retinopathy in TIME-2 study

February 11, 2016
AKB-9778 alone or in combination with ranibizumab improved underlying diabetic retinopathy in eyes with and without diabetic macular edema in the TIME-2 phase 2a study…
Breaking News

Doctors urge Congress to preserve the 340B Drug Pricing Program

February 11, 2016
Thousands of physicians from American safety-net hospitals signed a letter sent to Congress highlighting the importance of the 340B Drug Pricing Program.The letter asks…
More News Headlines »
Practical Retina

Comparing Aflibercept, Bevacizumab, and Ranibizumab for DME: Analysis of DRCR Protocol T

Ophthalmic Surgery, Lasers and Imaging Retina, March 2015, Volume 46 Issue 3
More »
CME

Best of Retina Forum: Focus on the Diabetic Eye

This activity is supported by educational grants from Allergan, Inc. and Regeneron Pharmaceuticals, Inc.

The management of diabetic eye disease has undergone significant changes over the last 18 months. Two steroid implants…
More »
Featured
Meeting News CoverageVideo

VIDEO: Surgeon says physician consulting necessary for drug, device development

February 4, 2016
More »
morganatic-roan morganatic-roan